Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

NCT04377997 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Diseases
COVID-19

Interventions

DRUG: Enoxaparin

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]